323 related articles for article (PubMed ID: 27465528)
1. Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.
Chheda ZS; Sharma RK; Jala VR; Luster AD; Haribabu B
J Immunol; 2016 Sep; 197(5):2016-26. PubMed ID: 27465528
[TBL] [Abstract][Full Text] [Related]
2. Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity.
Sharma RK; Chheda Z; Jala VR; Haribabu B
J Immunol; 2013 Sep; 191(6):3462-70. PubMed ID: 23960231
[TBL] [Abstract][Full Text] [Related]
3. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
4. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
[TBL] [Abstract][Full Text] [Related]
5. The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness.
Taube C; Miyahara N; Ott V; Swanson B; Takeda K; Loader J; Shultz LD; Tager AM; Luster AD; Dakhama A; Gelfand EW
J Immunol; 2006 Mar; 176(5):3157-64. PubMed ID: 16493075
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial immunotherapy induces tumor-infiltrating CD8
Van Braeckel-Budimir N; Dolina JS; Wei J; Wang X; Chen SH; Santiago P; Tu G; Micci L; Al-Khami AA; Pfister S; Ram S; Sundar P; Thomas G; Long H; Yang W; Potluri S; Salek-Ardakani S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903555
[TBL] [Abstract][Full Text] [Related]
7. Absence of LTB4/BLT1 axis facilitates generation of mouse GM-CSF-induced long-lasting antitumor immunologic memory by enhancing innate and adaptive immune systems.
Yokota Y; Inoue H; Matsumura Y; Nabeta H; Narusawa M; Watanabe A; Sakamoto C; Hijikata Y; Iga-Murahashi M; Takayama K; Sasaki F; Nakanishi Y; Yokomizo T; Tani K
Blood; 2012 Oct; 120(17):3444-54. PubMed ID: 22936657
[TBL] [Abstract][Full Text] [Related]
8. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.
Yue C; Shen S; Deng J; Priceman SJ; Li W; Huang A; Yu H
Cancer Immunol Res; 2015 Aug; 3(8):864-870. PubMed ID: 26025380
[TBL] [Abstract][Full Text] [Related]
9. Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness.
Miyahara N; Takeda K; Miyahara S; Matsubara S; Koya T; Joetham A; Krishnan E; Dakhama A; Haribabu B; Gelfand EW
Am J Respir Crit Care Med; 2005 Jul; 172(2):161-7. PubMed ID: 15849325
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
[TBL] [Abstract][Full Text] [Related]
11. The yin and yang of leukotriene B
Jala VR; Bodduluri SR; Satpathy SR; Chheda Z; Sharma RK; Haribabu B
Semin Immunol; 2017 Oct; 33():58-64. PubMed ID: 28982616
[TBL] [Abstract][Full Text] [Related]
12. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis.
Kim ND; Chou RC; Seung E; Tager AM; Luster AD
J Exp Med; 2006 Apr; 203(4):829-35. PubMed ID: 16567386
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy.
Chow MT; Ozga AJ; Servis RL; Frederick DT; Lo JA; Fisher DE; Freeman GJ; Boland GM; Luster AD
Immunity; 2019 Jun; 50(6):1498-1512.e5. PubMed ID: 31097342
[TBL] [Abstract][Full Text] [Related]
14. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.
Medoff BD; Seung E; Wain JC; Means TK; Campanella GS; Islam SA; Thomas SY; Ginns LC; Grabie N; Lichtman AH; Tager AM; Luster AD
J Exp Med; 2005 Jul; 202(1):97-110. PubMed ID: 15998790
[TBL] [Abstract][Full Text] [Related]
15. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
[TBL] [Abstract][Full Text] [Related]
16. Exercise Training Improves Tumor Control by Increasing CD8
Gomes-Santos IL; Amoozgar Z; Kumar AS; Ho WW; Roh K; Talele NP; Curtis H; Kawaguchi K; Jain RK; Fukumura D
Cancer Immunol Res; 2021 Jul; 9(7):765-778. PubMed ID: 33839688
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids enhance CD8+ T cell-mediated airway hyperresponsiveness and allergic inflammation by upregulating leukotriene B4 receptor 1.
Ohnishi H; Miyahara N; Dakhama A; Takeda K; Mathis S; Haribabu B; Gelfand EW
J Allergy Clin Immunol; 2008 Apr; 121(4):864-71.e4. PubMed ID: 18395551
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection.
Wuest TR; Carr DJ
J Immunol; 2008 Dec; 181(11):7985-93. PubMed ID: 19017990
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.
Sharma RK; Chheda ZS; Jala VR; Haribabu B
Expert Rev Vaccines; 2015 Apr; 14(4):537-49. PubMed ID: 25482400
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
